QCG
GMED icon

Quadrant Capital Group’s Globus Medical GMED Stock Holding History

Quadrant Capital Group’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$246K Sell
3,114
-724
-19% -$61.5K 0.01% 1151
2026
Q1 		$331K Sell
3,838
-3,979
-51% -$357K 0.01% 1089
2025
Q4 		$683K Buy
7,817
+5,237
+203% +$397K 0.02% 756
2025
Q3 		$148K Buy
+2,580
New +$149K ﹤0.01% 1361
2025
Q2 		– Sell
-2,933
Closed -$215K – 1849
2025
Q1 		$215K Buy
2,933
+2,726
+1,317% +$225K 0.01% 1258
2024
Q4 		$17.1K Buy
207
+112
+118% +$8.83K ﹤0.01% 1955
2024
Q3 		$6.8K Hold
95
– – ﹤0.01% 2249
2024
Q2 		$6.51K Buy
95
+35
+58% +$2.09K ﹤0.01% 2234
2024
Q1 		$3.22K Buy
60
+13
+28% +$699 ﹤0.01% 2412
2023
Q4 		$2.5K Sell
47
-445
-90% -$21.7K ﹤0.01% 2428
2023
Q3 		$24.4K Buy
492
+353
+254% +$19.7K ﹤0.01% 1612
2023
Q2 		$8.28K Hold
139
– – ﹤0.01% 2073
2023
Q1 		$7.87K Sell
139
-90
-39% -$5.77K ﹤0.01% 2115
2022
Q4 		$17K Buy
229
+19
+9% +$1.29K ﹤0.01% 1728
2022
Q3 		$13K Buy
210
+139
+196% +$8.37K ﹤0.01% 1761
2022
Q2 		$4K Buy
71
+7
+11% +$460 ﹤0.01% 2034
2022
Q1 		$5K Buy
64
+14
+28% +$973 ﹤0.01% 1905
2021
Q4 		$4K Sell
50
-4
-7% -$290 ﹤0.01% 1950
2021
Q3 		$4K Buy
54
+6
+13% +$482 ﹤0.01% 1940
2021
Q2 		$4K Buy
48
+19
+66% +$1.35K ﹤0.01% 1914
2021
Q1 		$2K Sell
29
-1
-3% -$63 ﹤0.01% 2061
2020
Q4 		$2K Buy
30
+8
+36% +$460 ﹤0.01% 1943
2020
Q3 		$1K Sell
22
-35
-61% -$1.8K ﹤0.01% 1975
2020
Q2 		$3K Buy
57
+35
+159% +$1.69K ﹤0.01% 1801
2020
Q1 		$1K Buy
+22
New +$1.09K ﹤0.01% 1987
2019
Q3 		– Sell
-904
Closed -$38K – 2328
2019
Q2 		$38K Buy
904
+425
+89% +$18.5K 0.01% 1335
2019
Q1 		$23K Buy
+479
New +$21.7K ﹤0.01% 1501

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Quadrant Capital Group's GMED Position: Q2 2026 in Review

Quadrant Capital Group reduced its Globus Medical (GMED) stake by 19% in Q2 2026, selling an estimated $61.5K and leaving 3,114 shares worth $246K. The position accounts for 0.01% of the portfolio, ranked #1151.

Quadrant Capital Group first reported a position in GMED in Q1 2019 and has held it in 27 quarters since. The position peaked at $683K in Q4 2025. 597 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Quadrant Capital Group held 3,114 shares of Globus Medical worth $246K as of Q2 2026.
  • Quadrant Capital Group sold 724 Globus Medical shares in Q2 2026, an estimated $61.5K.
  • Globus Medical made up 0.01% of Quadrant Capital Group's portfolio in Q2 2026, its #1151 holding.
  • Quadrant Capital Group first reported a position in Globus Medical in Q1 2019 and has held it in 27 quarters since.
  • Quadrant Capital Group's Globus Medical position peaked at $683K in Q4 2025.
  • 597 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.